Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 6901-6909

  Eissmann, Philipp ^a   Evans, J Henry ^a   Mehrabi, Maryam ^a   Rose, Emma L ^a   Nedvetzki, Shlomo ^a   Davis, Daniel M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE RAD3; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; MESSENGER RNA; MHC CLASS I CHAIN GENE FAMILY RELATED MOLECULE; MICRORNA; NATURAL KILLER CELL RECEPTOR NKG2D; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; TLR4 PROTEIN, HUMAN;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGATION; MACROPHAGE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; BIOSYNTHESIS; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTOR CROSS-TALK; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 77953642977     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903985     Document Type: Article

References (51)

1. Raulet, D. H., and N. Guerra. 2009. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat. Rev. Immunol. 9: 568-580.
2. Gleimer, M., and P. Parham. 2003. Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity 19: 469-477. (Pubitemid 37311429)
3. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729. (Pubitemid 129505074)
4. Wu, J., Y. Song, A. B. Bakker, S. Bauer, T. Spies, L. L. Lanier, and J. H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285: 730-732.
5. Eagle, R. A., J. A. Traherne, J. R. Hair, I. Jafferji, and J. Trowsdale. 2009. ULBP6/RAET1L is an additional human NKG2D ligand. Eur. J. Immunol. 39: 3207-3216.
6. Gasser, S., and D. H. Raulet. 2006. Activation and self-tolerance of natural killer cells. Immunol. Rev. 214: 130-142.
7. Guerra, N., Y. X. Tan, N. T. Joncker, A. Choy, F. Gallardo, N. Xiong, S. Knoblaugh, D. Cado, N. M. Greenberg, N. R. Greenberg, and D. H. Raulet. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28: 571-580.
8. O'Neill, L. A. J. 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226: 10-18.
9. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
10. Rittirsch, D., M. A. Flierl, and P. A.Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8: 776-787.
11. Orange, J. S. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4: 1545-1558. (Pubitemid 36050824)
12. Hamerman, J. A., K. Ogasawara, and L. L. Lanier. 2004. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172: 2001-2005.
13. Nedvetzki, S., S. Sowinski, R. A. Eagle, J. Harris, F. Vély, D. Pende, J. Trowsdale, E. Vivier, S. Gordon, and D. M. Davis. 2007. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109: 3776-3785.
14. Bahram, S., H. Inoko, T. Shiina, and M. Radosavljevic. 2005. MIC and other NKG2D ligands: from none to too many. Curr. Opin. Immunol. 17: 505-509.
15. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
16. Nice, T. J., L. Coscoy, and D. H. Raulet. 2009. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. J. Exp. Med. 206: 287-298.
17. Kaiser, B. K., D. Yim, I. T. Chow, S. Gonzalez, Z. Dai, H. H. Mann, R. K. Strong, V. Groh, and T. Spies. 2007. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447: 482-486.
18. Waldhauer, I., D. Goehlsdorf, F. Gieseke, T. Weinschenk, M. Wittenbrink, A. Ludwig, S. Stevanovic, H. G. Rammensee, and A. Steinle. 2008. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68: 6368-6376.
19. Yadav, D., J. Ngolab, R. S. Lim, S. Krishnamurthy, and J. D. Bui. 2009. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA. J. Immunol. 182: 39-43.
20. Stern-Ginossar, N., C. Gur, M. Biton, E. Horwitz, M. Elboim, N. Stanietsky, M. Mandelboim, and O. Mandelboim. 2008. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol. 9: 1065-1073.
21. Groh, V., S. Bahram, S. Bauer, A. Herman,M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93: 12445-12450.
22. Boissel, N., D. Rea, V. Tieng, N. Dulphy, M. Brun, J. M. Cayuela, P. Rousselot, R. Tamouza, P. Le Bouteiller, F. X. Mahon, et al. 2006. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J. Immunol. 176: 5108-5116.
23. Carlin, L. M., K. Eleme, F. E. McCann, and D. M. Davis. 2001. Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J. Exp. Med. 194: 1507-1517.
24. Pende, D., P. Rivera, S. Marcenaro, C. C. Chang, R. Biassoni, R. Conte, M. Kubin, D. Cosman, S. Ferrone, L. Moretta, and A. Moretta. 2002. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62: 6178-6186. (Pubitemid 35244469)
25. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
26. Salio, M., A. O. Speak, D. Shepherd, P. Polzella, P. A. Illarionov, N. Veerapen, G. S. Besra, F. M. Platt, and V. Cerundolo. 2007. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc. Natl. Acad. Sci. USA 104: 20490-20495.
27. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
28. Sheikh, N. A., and L. A. Jones. 2008. CD54 is a surrogate marker of antigen presenting cell activation. Cancer Immunol. Immunother. 57: 1381-1390.
29. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59: 423-450.
30. Soriani, A., A. Zingoni, C. Cerboni, M. L. Iannitto, M. R. Ricciardi, V. Di Gialleonardo, M. Cippitelli, C. Fionda, M. T. Petrucci, A. Guarini, et al. 2009. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
31. Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59: 4375-4382.
32. Horrigan, L. A., J. P. Kelly, and T. J. Connor. 2006. Immunomodulatory effects of caffeine: friend or foe? Pharmacol. Ther. 111: 877-892.
33. Hickson, I., Y. Zhao, C. J. Richardson, S. J. Green, N. M. Martin, A. I. Orr, P. M. Reaper, S. P. Jackson, N. J. Curtin, and G. C. Smith. 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64: 9152-9159.
34. Griffiths-Jones, S., H. K. Saini, S. van Dongen, and A. J. Enright. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36(Database issue): D154-D158.
35. Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A. O. Kamphorst, M. Landthaler, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414. (Pubitemid 46970709)
36. Meister, G., M. Landthaler, Y. Dorsett, and T. Tuschl. 2004. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550. (Pubitemid 38241013)
37. Nachmani, D., N. Stern-Ginossar, R. Sarid, and O. Mandelboim. 2009. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
38. Kloss, M., P. Decker, K. M. Baltz, T. Baessler, G. Jung, H. G. Rammensee, A. Steinle, M. Krusch, and H. R. Salih. 2008. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J. Immunol. 181: 6711-6719.
39. Newman, K. C., and E. M. Riley. 2007. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7: 279-291.
40. Lapaque, N., T. Walzer, S. Méresse, E. Vivier, and J. Trowsdale. 2009. Interactions between human NK cells and macrophages in response to Salmonella infection. J. Immunol. 182: 4339-4348.
41. Basu, S., M. Eriksson, P. A. Pioli, J. Conejo-Garcia, T. F. Mselle, S. Yamamoto, C. R. Wira, and C. L. Sentman. 2009. Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPs. Am. J. Reprod. Immunol. 61: 52-61.
42. Stern-Ginossar, N., and O. Mandelboim. 2009. An integrated view of the regulation of NKG2D ligands. Immunology 128: 1-6.
43. Cerboni, C., A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni. 2007. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 110: 606-615. (Pubitemid 47105399)
44. Ward, J., Z. Davis, J. DeHart, E. Zimmerman, A. Bosque, E. Brunetta, D. Mavilio, V. Planelles, and E. Barker. 2009. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 5: e1000613.
45. Tang, K. F., H. Ren, J. Cao, G. L. Zeng, J. Xie, M. Chen, L. Wang, and C. X. He. 2008. Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB. J. Cell Biol. 182: 233-239.
46. Butler, J. E.,M.B.Moore, S.R. Presnell, H.-W.Chan, N. J.Chalupny, and C.T. Lutz. 2009. Proteasome regulation of ULBP1 transcription. J. Immunol. 182: 6600-6609.
47. Eagle, R. A., and J. Trowsdale. 2007. Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 7: 737-744.
48. Esclatine, A., B. Taddeo, and B. Roizman. 2004. The UL41 protein of herpes simplex virus mediates selective stabilization or degradation of cellular mRNAs. Proc. Natl. Acad. Sci. USA 101: 18165-18170.
49. Eulalio, A., E. Huntzinger, and E. Izaurralde. 2008. Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14.
50. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
51. Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.